Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Langer

Showing results (431-440 of 596) with videos related to

Pageof 60
Sort By:
JCO Precision Oncology|August 21, 2019
Impact of <i>KRAS</i> and <i>TP53</i> Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With <i>STK11</i>-Mutated Advanced Non-Small-Cell Lung CancerErin Bange, Melina E Marmarelis, Wei-Ting Hwang, et al.
Journal of Experimental Therapeutics & Oncology|May 24, 2018
Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastomaKay O Kulason, Julia R Schneider, Shamik Chakraborty, et al.
Clinical Lung Cancer|May 9, 2017
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III StudiesCorey J Langer, Luis G Paz-Ares, Antoinette J Wozniak, et al.
Brain, Behavior, and Immunity|December 19, 2006
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in ratsAnnemarie Ledeboer, Brian M Jekich, Evan M Sloane, et al.
Practical Radiation Oncology|February 5, 2015
Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating studyEric P Xanthopoulos, Elizabeth Handorf, Charles B Simone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical responseRamesh Rengan, Rosemarie Mick, Daniel Pryma, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 15, 2000
Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimensM Hindiyeh, C Goulding, H Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trialGeorge R Simon, Claire F Verschraegen, Pasi A Jänne, et al.
The European Journal of Neuroscience|May 5, 2005
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10Erin D Milligan, Stephen J Langer, Evan M Sloane, et al.
American Journal of Clinical Oncology|March 21, 2013
ACR Appropriateness Criteria® radiation therapy for small-cell lung cancerFeng-Ming Kong, Brian E Lally, Joe Yujiao Chang, et al.
Pageof 60

Showing results (431-440 of 596) with videos related to

Sort By:
Pageof 60
JCO Precision Oncology|August 21, 2019
Impact of <i>KRAS</i> and <i>TP53</i> Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With <i>STK11</i>-Mutated Advanced Non-Small-Cell Lung CancerErin Bange, Melina E Marmarelis, Wei-Ting Hwang, et al.
Journal of Experimental Therapeutics & Oncology|May 24, 2018
Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastomaKay O Kulason, Julia R Schneider, Shamik Chakraborty, et al.
Clinical Lung Cancer|May 9, 2017
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III StudiesCorey J Langer, Luis G Paz-Ares, Antoinette J Wozniak, et al.
Brain, Behavior, and Immunity|December 19, 2006
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in ratsAnnemarie Ledeboer, Brian M Jekich, Evan M Sloane, et al.
Practical Radiation Oncology|February 5, 2015
Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating studyEric P Xanthopoulos, Elizabeth Handorf, Charles B Simone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical responseRamesh Rengan, Rosemarie Mick, Daniel Pryma, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 15, 2000
Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimensM Hindiyeh, C Goulding, H Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trialGeorge R Simon, Claire F Verschraegen, Pasi A Jänne, et al.
The European Journal of Neuroscience|May 5, 2005
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10Erin D Milligan, Stephen J Langer, Evan M Sloane, et al.
American Journal of Clinical Oncology|March 21, 2013
ACR Appropriateness Criteria® radiation therapy for small-cell lung cancerFeng-Ming Kong, Brian E Lally, Joe Yujiao Chang, et al.
Pageof 60